Combination treatment for depression and anxiety

Details Combination treatment for depression and anxiety Combination treatment for depression and anxiety

A - Human Necessities

61

K

A61K 31/451 (2006.01) A61K 31/075 (2006.01) A61K 31/085 (2006.01) A61K 31/135 (2006.01) A61K 31/137 (2006.01) A61K 31/165 (2006.01) A61K 31/277 (2006.01) A61K 31/341 (2006.01) A61K 31/381 (2006.01) A61K 31/4015 (2006.01) A61K 31/41 (2006.01) A61K 31/415 (2006.01) A61K 31/4192 (2006.01) A61K 31/4196 (2006.01) A61K 31/425 (2006.01) A61K 31/4418 (2006.01) A61P 25/24 (2006.01)

Patent

CA 2386287

-53- The present invention relates to a method of treating depression or anxiety in a mammal, including a human, by administering to the mammal a monoamine reuptake inhibitor in combination with a dopamine D3 receptor agonist. It also relates to pharmaceutical compositions containing a pharmaceutically acceptable carrier, a monoamine reuptake inhibitor and a dopamine D3 receptor agonist.

Affiliated with

Also associated with

Rating

Combination treatment for depression and anxiety does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination treatment for depression and anxiety, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination treatment for depression and anxiety will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1950162